The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637)

NCT00831662 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

490

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease

Interventions

DRUG: Diquafosol tetrasodium ophthalmic solution, 2%
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC